Liquid biopsies provide better therapy options for more patients.
Hedera Dx is on a mission to provide the next billion people with access to modern cancer care.
We specialize in clinic-ready, NGS-based liquid biopsies that enable non-invasive diagnosis, timely treatment selection, and longitudinal disease monitoring.
Our culture is based on thinking different, modern and human, fostering a dynamic and innovative work environment.
Join us on hederadx.com to learn more!
Company Details
- Employees
- 27
- Founded
- 2021
- Address
- Route De La Corniche 5, Bâtiment Alanine,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.hederadx.com
- Keywords
- Oncology, Next-Generation Sequencing, Liquid Biopsy, ctDNA, IVDR Compliance, Medical Device, Precision Medicine, RWE.
- HQ
- Epalinges, Vaud
Hedera Dx Questions
Hedera Dx's website is https://www.hederadx.com
Hedera Dx's LinkedIn profile is https://ch.linkedin.com/company/hedera-dx
Hedera Dx has
27 employees.
View email and phone details for 27
employees at Hedera Dx.
Hedera Dx's industry is
Biotechnology Research
Hedera Dx's top competitors are
Haya Therapeutics,
Axelera Ai,
Crescendo,
Unique,
Windward Bio,
Moonlight Ai,
Novigenix Sa,
Adaptyv,
Sophia Genetics,
Cradle.
Hedera Dx's categories are Biotechnology Research
Hedera Dx's founding year is 2021
